Masaharu Hanai

Anti-tumour activity of CS-7017, a selective peroxisome proliferator-activated receptor gamma agonist of thiazolidinedione class, in human tumour xenografts and a syngeneic tumour implant model

Naomi Shimazaki, Noriko Togashi, Masaharu Hanai et al. · European Journal of Cancer · 2008 · 62 citations

Medicine, Oncology, Pharmacology +6

Therapeutic effect of CS-706, a specific cyclooxygenase-2 inhibitor, on gallbladder carcinoma in BK5.ErbB-2 mice

Kaoru Kiguchi, Lynnsie Ruffino, Toru Kawamoto et al. · Molecular Cancer Therapeutics · 2007 · 23 citations · Full text

Medicine, Oncology, Pharmacology +12

Preclinical Development of U3-1784, a Novel FGFR4 Antibody Against Cancer, and Avoidance of Its On-target Toxicity

René Bartz, Keisuke Fukuchi, Toshiaki Ohtsuka et al. · Molecular Cancer Therapeutics · 2019 · 23 citations · Full text

Medicine, Oncology, Pharmacology +17

CS‐706, a novel cyclooxygenase‐2 selective inhibitor, prolonged the survival of tumor‐bearing mice when treated alone or in combination with anti‐tumor chemotherapeutic agents

Michiyo Senzaki, Saori Ishida, Ayumi Yada et al. · International Journal of Cancer · 2007 · 17 citations

Medicine, Oncology, Pharmacology +13